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The Vpr gene of human immunodeficiency virus type 1 and type 2 (HIV-1, HIV-2) and simian immunodeficiency virus (SIV)
encodes a small nuclear protein which is virion-associated and assists nuclear transport of the preintegration complex.
Expression of HIV-1 Vpr has been shown to induce differentiation and prevent proliferation of human cells. HIV-1 Vpr has
also been shown to arrest cell growth and cause morphological defects in yeast. In contrast, the Vpx gene of HIV-2 and
SIV, which shares sequence homology with Vpr, does not seem to inhibit proliferation of human cells. It has been suggested
that the cell cycle arrest effect of Vpr and Vpx is species and cell-type dependent. In this study, we have taken advantage
of a conditional expression system to characterize the growth inhibitory effects of Vpr and Vpx of HIV-1, HIV-2, and SIV in
the fission yeast Schizosaccharomyces pombe. Our results show that both Vpr and/or Vpx of HIV-1, HIV-2, and SIV arrest
cell growth in S. pombe, and HIV-1 Vpr is more cytotoxic than HIV-2 or SIV Vpr or Vpx. Flow cytometry analysis indicated
that yeast cells cease proliferating with DNA contents indicative of arrest in G1 and G2 , with some cells showing signs of
overreplication of DNA. While the observed cell cycle arrest phenotype was not identical to that observed in mammalian
cells, there were similarities of growth arrest phenotype caused by Vpr and Vpx in yeast and mammalian cells. Specifically,
the observation that yeast and mammalians cell both arrest in G2 with reduced p34/cdc2 kinase activity indicates that Vpr
and Vpx interact with conserved target(s) in yeast and mammalian cells. The ability to use genetic analysis to elucidate the
mechanisms involved makes S. pombe an excellent model system in which to study the effects of Vpr and Vpx on cellular
function. q 1997 Academic Press
INTRODUCTION of either Vpr or Vpx (Franchini and Reitz, 1994; Subbra-
manian and Cohen, 1994; Tristem et al., 1992). HIV-1/
The lentiviruses, human immunodeficiency virus type 1 SIVcpz , SIVmad , and SIVsyk contain the Vpr gene only. HIV-
(HIV-1) and type 2 (HIV-2), and simian immunodeficiency 2/SIVsm/SIVmac contains both Vpr and Vpx, whereas SIVagm
virus (SIV), have been identified as the etiologic agents encodes Vpx only. Since the Vpr and Vpx proteins are
of human acquired immunodeficiency syndrome (AIDS) found in mature virions, it has been thought they play a
and simian AIDS, respectively (Levy, 1995). HIV-1, HIV- role in the early phase of the viral life cycle (Aldrovandi
2, and SIV contain, in addition to the gag, pol, and env and Zack, 1996; Cohen et al., 1990; Levy, 1995; Yu et al.,
structural genes, small open reading frames encoding 1990). Recent studies suggest that Vpr and the matrix
the accessory proteins Tat, Rev, Nef, Vpr and/or Vpx, protein of HIV-1 are required for nuclear migration of the
Vpu, and Vif (Vaishnav and Wong-Staal, 1991). These preintegration complex (Bukrinsky et al., 1993; Hein-
genes are highly conserved between HIV-1, HIV-2, and zinger et al., 1994). Vpr has also been reported to prevent
SIV and have been found to play important regulatory establishment of chronically infected HIV-1 producer cell
roles during viral replication (Subbramanian and Cohen, lines (Planelles et al., 1996; Rogel et al., 1995). This is
1994; Trono, 1995). While these accessory proteins have consistent with an earlier report which showed that HIV-
been shown to be dispensable for virus replication in 1 Vpr expression could prevent cell division and induce
vitro, animal model studies of the SIVmac virus suggest differentiation of a rhabdomyosarcoma cell line (Levy et
these proteins are important in virus replication and al., 1993). More recent studies have shown that HIV-1
pathogenesis in vivo (Aldrovandi and Zack, 1996; Desro- Vpr can arrest the cell cycle in G2 phase in mammalian
siers, 1990; Gibbs et al., 1995; Lang et al., 1993; Trono, cells, possibly via inhibition of p34/cdc2 kinase activity
1995). (Bartz et al., 1996; He et al., 1995; Jowett et al., 1995;
The Vpr and Vpx genes are related, with all five groups Paxton et al., 1993; Planelles et al., 1996; Re et al., 1995).
of primate lentiviruses containing at least one homologue HIV-1 Vpr has also been reported to arrest cell growth
of yeast (Macreadie et al., 1995; Zhao et al., 1996). In
addition, HIV-2 and SIV Vpr have been shown to cause1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (403) 492-7660. cell cycle arrest in mammalian cells, although the effects
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of HIV-2 and SIV Vpr were not as pronounced as that of HIV-2ROD Vpr
5* primer CTCTCTCATATGGCTGAAGCACCAACAHIV-1 Vpr. In fact, Vpx from HIV-2 and SIVmac did not
induce cell cycle arrest in monkey CV-1 or human HeLa 3* primer AAACGGATCCTTATTGCATGTTTCTAGG
HIV-2ROD Vpxand 293 cells (Marzio et al., 1995; Planelles et al., 1996).
The yeast S. pombe has been widely used as a model 5* primer CTCTCTCATATGACAGACCCCAGAGAG
3* primer AAACGGATCCTTAGACCAGACCTGGAGGto study the role of a variety of genes in the control of
cell proliferation in eukaryotic cells (Draetta et al., 1987;
All PCR products were subcloned into pGEM7Zf(/)Nurse, 1994). Therefore, we reasoned that if expression
and sequenced to ensure that no errors had occurredof Vpr and Vpx proteins in fission yeast could produce
during amplification. The fragments were then excisedobservable phenotypes, it would provide us with an in
by digestion with NdeI and BamHI and subcloned intovivo model system with which to study the effects of
the expression plasmid pREP41. The expression plasmidthese proteins on cell function, especially cell prolifera-
pREP41 contains the nmt1 promoter which is repressedtion, and the molecular mechanisms involved. In this re-
in the presence of thiamine (Maundrell, 1990). After liga-port, we have studied the effect of HIV-1 Vpr, HIV-2 Vpr/
tion into pREP41, each construct was sequenced to en-Vpx, and SIV-Vpr/Vpx expression on cell cycle progres-
sure that the orientation and translation start sites weresion in S. pombe. We have found that expression of HIV-
correct.1 Vpr in fission yeast blocks cell proliferation with cells
arrested predominantly in the G1 and G2 phases of the
Culture and transformation of S. pombecell cycle. In addition HIV-1 Vpr expression was cytotoxic
with cell viability rapidly declining in the presence of The yeast strains used in this study were SP130 (h-,
HIV-1 Vpr. In addition, although Vpr expression induced ade6-210, leu1-32) and cdc2-1w and cdc2-3w (Rasmus-
polyploidy in yeast as in mammalian cells, the cytotoxic sen and Rasmussen, 1994). The growth medium was
effects in yeast contrasted with previous studies in hu- minimal medium (MM) with or without the supplements
man T cell lines where Vpr expression was found to be of leucine, adenine, and uracil according to the selection
cytostatic rather than cytotoxic (Bartz et al., 1996). Fur- requirements of each particular strain. Standard culture
ther, although SIV Vpx has been reported to be noncyto- conditions and techniques were used as described (Mor-
static in mammalian cells (Paxton et al., 1993; Planelles eno et al., 1991). Strains containing pREP41-based ex-
et al., 1996), expression of either HIV-2 Vpr/Vpx or SIV- pression plasmids were routinely grown in medium con-
Vpr/Vpx resulted in yeast cell arrest. However, the effect taining 1 mM thiamine–HCl to repress nmt1-dependent
on cell viability was not as pronounced as with HIV-1 transcription. To permit expression from the nmt1 pro-
Vpr. Expression of the Tat protein produced none of moter, cells were washed with sterile water and then
these phenotypes, indicating that the effects are specific reinoculated into MM lacking thiamine–HCl. Transfor-
to Vpr and Vpx. Thus, these studies indicate that S. mation of S. pombe was carried out by the lithium acetate
pombe may be a useful model system with which to procedure as described elsewhere (Moreno et al., 1991).
study the processes through which Vpr and Vpx affect
cellular function. Western blot analysis of Vpr and Vpx expression
Protein extracts were prepared as described pre-MATERIALS AND METHODS
viously (Moreno et al., 1991). For Western blot analysis,
Plasmid construction protein concentrations of extracts were quantified using
the DC Protein Assay (Bio-Rad). Ten micrograms of pro-The following primer combinations were used to pro-
tein from each sample was applied to a 10–20% gradientduce Vpr and Vpx fragments for ligation into the pREP41
Tricine–SDS–PAGE gel (NOVEX, Canada). After electro-expression vector. All are listed in the 5*-3* direction.
phoresis, the proteins were transferred to nitrocellulose
membranes (Schleicher and Schuell). Filters were air-HIV-1NL4-3 Vpr
5* primer GAGGACATAGGAACAAGCC dried then blocked with 10% dried milk in TBST (50 mM
Tris, pH 7.5, 150 mM NaCl, 0.3% Tween-20) for 1 hr at3* primer CCCGGATCCTAGGATCTACTGGCTCC
HIV-1NL4-3 Tat room temperature. Filters were then incubated with the
primary antibody (rabbit anti-HIV-1 Vpr, rabbit anti-HIV-15* primer CTCTCTCATATGGAGCCAGTAGATCCT
3* primer AAACGGATCCCTAATCGTACGGATCTGT Tat, rabbit anti-SIV Vpr, or rabbit anti-SIV Vpx) at 1:500
to 1:1000 dilution at 47 overnight. This was followed by anSIVMAC239 Vpr
5* primer CAGAGGACATATGGAAGAAAGACCTCC incubation with an HRP-conjugated secondary antibody
(Amersham, NA 9340, 1:2000 dilution) at room tempera-3* primer CCCGGATCCCATGCTTCTAGAGGGCGG
SIVMAC239 Vpx ture for 1 hr. After washing the filter, the antibody was
localized using ECL Western Blotting Detection Reagents5* primer CAGAGGACATATGTCAGATCCCAGGGA
3* primer CCCGGATCCTTATGCTAGTCCTGGAGG (Amersham Life Science).
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Flow cytometry 18, and 24 hr), an aliquot of culture was harvested, cell
density determined, and approximately 200 cells fromThe cell samples for flow cytometry were prepared
each sample were plated onto thiamine-plus plate. Theas described previously (Alfa et al., 1992). Briefly, yeast
plates were incubated at 307 for 4–6 days prior to count-cultures were grown at 307 overnight to a density of 1 1
ing colonies.107 cells/ml and cells were collected by centrifugation.
The cells were fixed with 70% ethanol and kept at 47 until
RESULTSuse. For FACS analysis, an aliquot of the fixed cells
(about 3 1 106) was collected and washed once with 1
Construction of thiamine-conditional Vpr and Vpx
ml of 50 mM sodium citrate (pH 7.0). The cells were
expression plasmids
resuspended in 0.5 ml, 50 mM sodium citrate containing
0.1 mg/ml RNaseA, and incubated in a 377 water bath To engineer the Vpr and Vpx expression vectors, we
for 2 hr. After incubation, 0.5 ml 50 mM sodium citrate amplified the Vpr gene of the clone HIV-1NL4-3 and the
containing 2 mg/ml propidium iodide was added to the Vpr and Vpx genes of HIV-2ROD and SIVMAC239 by PCR.
cells. The DNA content was determined by FACScan The PCR products were subcloned into pGEM7Zf(/) and
analysis and the data was analyzed using the CellFit sequenced to ensure there were no errors due to the
program (Becton–Dickinson). PCR. Each fragment was then excised by digestion with
NdeI and BamHI and cloned into the plasmid pREP41,Histone H1 kinase assay
3* to the thiamine-repressible nmt1 promoter. pREP41
The yeast protein extract was made as described contains the S. cerevisiae LEU2 gene which comple-
above. Cells were lysed using glass beads in a lysis ments the leu1-32 mutation of S. pombe. These plasmids
buffer composed of 25 mM Tris, pH 8.0, 10 mM MgCl2 , were transformed into the S. pombe strain SP130 (which
15 mM EGTA, 0.1% Triton X-100, 0.1 mM NaF, 60 mM b- carries the leu1-32 mutation) and transformants were se-
glycerophosphate, 15 mM p-nitrophenylphosphate, 0.1 lected by their ability to grow on minimal medium lacking
mM Na orthovanadate, 0.1 mM PMSF, 1 mg/ml leupeptin, leucine. The medium also contained thiamine to prevent
10 mg/ml soybean trypsin inhibitor, 1 mg/ml aprotinin, 10 expression of Vpr or Vpx in case their presence was
mg/ml TPCK. Immulon-2 plates (Fisher Scientific) were lethal to S. pombe.
coated with a solution of 5 mg p13, purified as described
previously (Rasmussen and Rasmussen, 1994) in 100 HIV-1 Vpr, HIV-2 Vpr/Vpx, and SIV Vpr/Vpx arrest
ml, 50 mM sodium carbonate buffer, pH 9.6, and then S. pombe proliferation
incubated at room temperature overnight. The wells were
To determine if expression of either Vpr or Vpx wouldwashed once with PBS, then blocked with PBS con-
affect cell proliferation of S. pombe, yeast cells containingtaining 3% BSA for 1 hr at room temperature. To prepare
the Vpr or Vpx expression plasmids were grown on me-samples for assay, 200 mg of total protein were mixed
dium with or without thiamine. When grown on MM /with an equal volume of PBS containing 1% BSA. The
thiamine (which prevents expression), normal size yeastfinal volume was approximately 100–250 ml. The assay
colonies were formed from yeast cells transformed withsamples were added to the p13-coated microwells and
either the empty pREP41 vector, HIV-1 tat, HIV-1 Vpr, HIV-incubated at room temperature with slow constant shak-
2 Vpr or Vpx, and SIV Vpr or Vpx (Fig. 1A). On plates lackinging for at least 5 hr. The cells were washed three times
thiamine (which permits expression), control yeast cellswith PBS / 0.2% Triton X-100 and then washed once
transformed with the control plasmid formed normal sizewith kinase assay buffer (50 mM Tris, pH 7.4, 10 mM
colonies. However, there were no colonies formed by yeastMgCl2 , 1 mM DTT, plus protease and phosphatase inhibi-
expressing HIV-1 Vpr and smaller than normal coloniestors as in the extraction buffer). To start the assay, 100
formed by yeast expressing SIV Vpr or Vpx (Fig. 1B), orml of assay buffer containing 8.3 mg histone H1, 10 mM
HIV-2 Vpr or Vpx (not shown). These results suggest thatATP, 2.5 mCi [g32P]ATP was added to each well and then
Vpr and Vpx inhibit cell proliferation in S. pombe, and thethe microtiter plate was incubated for 30 min at 307. The
lack of colonies observed when HIV-1 Vpr was expressedreaction was stopped by adding 35 ml of 21 SDS–PAGE
suggested that the presence of this protein had a moresample buffer. Fifteen microliters was spotted onto 3MM
pronounced effect on cell proliferation.paper, incubated for 10 min in 10% TCA and 40 mM
Because both Vpr and Vpx caused arrested growth,sodium pyrophosphate, washed three times with 5%
each strain was characterized to examine the effect onTCA, followed by a brief rinse in 95% ethanol. The filters
cell proliferation kinetics. Exponentially growing cells cul-were air dried and quantified by liquid scintillation spec-
tured in MM / thiamine were washed in sterile watertrometry.
and inoculated into fresh MM //0 thiamine at a density
Viability assays of 1 1 105 cells/ml. Cell numbers were then determined
at various times. The normal generation time of SP130Cells were grown in thiamine-plus or thiamine-minus
medium at 307. At different time points (0, 6, 9, 12, 15, cells at 307 in minimal medium is about 3 hr. The genera-
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at different time points and HIV-1 Vpr or SIV Vpr or Vpx
expression was detected by Western blot as described
under Materials and Methods. The immunoblot results
indicated that Vpr and Vpx could be detected within 9 hr
after switching cells into medium lacking thiamine, and
the levels of expression were constant for at least 24 hr
(Fig. 3). Since cell proliferation rates showed difference
beginning at 9 hr, these results indicate that the arrest
of cell proliferation we observed is coincident with Vpr
or Vpx expression.
When examined by phase microscopy, cells express-
FIG. 1. Expression of Vpr and Vpx inhibits cell growth in S. pombe.
S. pombe transformed with pREP41, pREP41-HIV-1-Vpr, pREP41-SIV-
Vpr, or pREP41-SIV-Vpx were plated onto MM agar with ot without
thiamine and incubated at 307 for 3–6 days. The plates are labeled
as follows: (1) pREP41-SIV-Vpr; (2) pREP41; (3) pREP41-HIV-1-Vpr; (4)
pREP41-SIV-Vpr. (A) Cells grown in the presence of thiamine (repress-
ing conditions). (B) Cells grown in the absence of thiamine (expressing
conditions).
tion time of HIV-1 Vpr-, HIV-2, and SIV Vpr- or Vpx- condi-
tionally expressing strains grown in the presence of thia-
mine (i.e., not expressing) was similar to that of the wild-
type strain as expected (Figs. 2B and 2C). However, in
the absence of thiamine, expression of HIV-1 Vpr caused
a complete arrest of cell proliferation within 9–12 hr (Fig.
2A), whereas cells expressing HIV-2 Vpr or Vpx (Fig. 2B),
or SIV Vpr or Vpx (Fig. 2C), showed a reduced rate of
proliferation starting at 9 hr and eventual cessation of
proliferation by 30 hr after switching to conditions that
permit expression. The growth kinetics of cells express-
FIG. 2. Growth kinetics of cells expressing Vpr or Vpx. Cells wereing HIV-1 Tat was the same in medium with or without
grown in liquid MM with or without thiamine at 307. An aliquot of thethiamine (Fig. 2A), indicating that the effects on cell prolif-
cell culture was collected every 3 hr and cell density determined. The
eration were specific to Vpr and Vpx proteins and not initial cell innoculum was 11 105 cells/ml. (A) Growth kinetics of SP130
due to simply expressing viral proteins. cells alone, cells containing the Tat expression plasmid (//0 thiamine),
and cells containing the HIV-1 Vpr expression plasmid (//0 thiamine).Western blot analysis of Vpr and Vpx expression
(B) Growth kinetics of cells containing the HIV-2 Vpr or Vpx expression
To confirm the correlation between cell growth arrest plasmids (//0 thiamine). (C) Growth kinetics of cells containing the
SIV Vpr or Vpx expression plasmids (//0 thiamine).and Vpr or Vpx expression, yeast extracts were prepared
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cycle but permits cell growth to continue, similar to pre-
viously described cell division cycle (cdc) mutants.
Expression of HIV-1 Vpr is lethal in S. pombe
Since expression of Vpr and Vpx arrested cell prolifera-
tion in S. pombe, we were interested in determining
whether there were additional effects on cell viability. To
address this, expression of HIV-1 Vpr, HIV-2, and SIV Vpr
or Vpx was induced by growth in minimal medium lacking
thiamine for different lengths of time. Cells were then
plated onto MM / thiamine medium to again repress
Vpr or Vpx expression. As a control, cells were treated
FIG. 3. Western blot analysis of Vpr and Vpx expression. Cells grown
in the same way except they remained in MM/ thiaminein MM were harvested at different times following shift to thiamine-
for all parts of the experiment. The number of viablefree medium. Total protein extracts were prepared and protein levels
determined by Western blot analysis. Data are shown for HIV-1 Vpr, cells was determined by counting the number of colonies
SIV Vpr, and SIV Vpx. Similar induction kinetics were observed for HIV- formed.
1 Tat expression (not shown). The results show that cells expressing HIV-1 Vpr rap-
idly lose viability, with essentially no viable cells re-
maining after 15 hr in thiamine-free medium (Fig. 5). Thising HIV-1 Vpr, HIV-2 Vpr, Vpx, or SIV Vpr showed an
increased cell length (Fig. 4). Staining of nuclei with pro- corresponds to about 6 hr of Vpr expression. In contrast,
expression of Vpr or Vpx from HIV-2 or SIV showed muchpidium iodide indicated that arrested cells contain a sin-
gle nucleus (not shown). These data suggest that expres- less of a cytotoxic effect on S. pombe than did expression
of HIV-1 Vpr. After 24 hr of incubation, about 50% of thesion of Vpr or Vpx proteins arrests the nuclear division
FIG. 4. Morphology of cells expressing Vpr or Vpx. Exponentially growing cells grown in MM / thiamine were used to inoculate MM with or
without thiamine. Cells were incubated for a further 18 hr, and then collected and fixed for microscopic examination. The samples were as follows:
(A) HIV-1 Vpr cells / thiamine. SIV-Vpr and -Vpx cells have an identical phenotype in medium containing thiamine (repressing conditions) and so
are not shown. (B) HIV-1 Vpr cells 0 thiamine. (C) SIV Vpr cells 0 thiamine. (D) SIV Vpx cells 0 thiamine.
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t  6 hr, HU was added to the culture. At t  10 hr, cells
were washed in sterile water and inoculated into medium
lacking HU and thiamine to release them from the S-
phase block, but maintain Vpr or Vpx expression. At t 
20 hr samples were taken and prepared for flow cytome-
try. To establish that the HU treatment results in cell
cycle arrest, a sample of HIV-1 Vpr cells was taken at t
 10 hr (i.e., 4 hr in HU), prior to removal of the HU (Fig.
7A). As a control for recovery from the HU treatment,
cells containing the HIV-1 Vpr expression vector were
grown in the presence of thiamine for the entire experi-
ment, which included a 10-hr recovery period after re-FIG. 5. Viability of cells expressing Vpr or Vpx. Cells were grown in
MM with or without thiamine at 307. An aliquot of cells was collected moval of the HU (Fig. 7B). The results show that the
and 200 cells plated onto MM agar containing thiamine. Visible colo- control cells, in which Vpr expression was repressed,
nies were counted after 3–6 days and the data shown in the graph. were able to recover from HU treatment and progressThe control sample is cells containing the HIV-1 Vpr expression plasmid
through the cell cycle establishing a normal, predomi-grown on plates containing thiamine (repressing conditions).
nantly G2/M distribution of cells (compare Figs. 6C and
cells were still viable (Fig. 5). These data indicate that
expression of HIV-1 Vpr in S. pombe is lethal, while ex-
pression of HIV-2 or SIV Vpr or Vpx has a less severe,
although significant effect on cell survival.
Vpr and Vpx arrest the cell cycle at two points
In order to determine the point of cell cycle arrest in
Vpr or Vpx expressing cells, we used flow cytometry to
determine the DNA content in control cells or cells ex-
pressing Vpr or Vpx. The flow cytometry controls included
nitrogen starvation, which arrests cells predominantly in
G1 and glucose starvation, which arrests cells predomi-
nantly in G2 (Figs. 6A and 6B). Control HIV-1 Vpr cells
grown in the presence of thiamine shown the normal
distribution DNA contents with most cells being in the
G2 phase of the cell cycle (Fig. 6C). Cells containing the
HIV-1 Vpr or SIV Vpr or Vpx expression vectors, and
grown in the absence of thiamine for 18 hr, showed cells
with DNA contents characteristic of both G1 , and G2/M
cells, indicating that Vpr and Vpx expression blocks cell
cycle progression at two distinct points (Figs. 6D–6F). In
addition, cells expressing HIV-1 Vpr also showed signs
of extra DNA replication as evidenced by the peak of
cells with DNA contents in excess of the G2/M peak (Fig.
6D). This effect was not observed in cells expressing SIV
Vpr or SIV Vpx (Figs. 6E and 6F).
Because we observed evidence of yeast cells accumu-
FIG. 6. Flow cytometric analysis of Vpr and Vpx expressing cells.lated not only in G2/M but also in the G1 phase of cell
Cells were grown as indicated below prior to preparation for flowcycle, we wanted to determine if Vpr or Vpx expression
cytomtery as described under Materials and Methods. The position ofprevents progression through S phase. To do this we
the 1N (G1 DNA content) and 2N (G2 DNA content) peaks are shown
established a culture of cells in which Vpr or Vpx expres- by the gray bars. Controls for 1N and 2N peaks are shown in parts A
sion had just reached maximal levels (which normally and B. The control for exponentially growing S. pombe (plasmid con-
taining cells grown in thiamine containing medium) is shown in C.takes 9 hr under the conditions we have used in this
Experimental cultures (D–F) were washed in sterile water then placedstudy), and which had been grown for 4 hr in the pres-
into thiamine-free MM for 18 hr prior to preparation for flow cytometry.ence of hydroxyurea (HU) in order to arrest cells in early
(A) HIV-1 Vpr cells grown in nitrogen limiting medium (enriches for G1
S-phase. To do this, cells containing the HIV-1 Vpr or cells). (B) HIV-1 Vpr cells grown in glucose limiting medium (enriches
SIV Vpr or Vpx vectors were switched to thiamine-free for G2 cells). (C) HIV1 Vpr / thiamine. (D) HIV1 Vpr 0 thiamine. (E)
SIV Vpr 0 thiamine. (F) SIV Vpx 0 thiamine.medium at t  0 hr to permit Vpr or Vpx expression. At
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in S. pombe, we asked whether p34/cdc2 activity was
inhibited by either Vpr or Vpx expression. To test this,
H1 kinase assays were carried out as described under
Materials and Methods to measure p34/cdc2 kinase ac-
tivity in control cells and cells expressing HIV-1 Vpr or
SIV Vpr or Vpx. The expression of HIV-1 Vpr or SIV Vpr or
Vpx caused similar decreases in p34/cdc2 kinase activity
(Fig. 8). These results also suggest that the cell cycle
arrest we have observed is associated with a loss of
p34/cdc2 kinase activity.
The activity of p34/cdc2 in S. pombe is positively regu-
lated by the cdc25 protein phosphatase, and negatively
regulated by the wee1 and mik1 kinases (Nurse, 1994).
Since we observed a decrease in p34/cdc2 activity in
cells expressing Vpr or Vpx, we wondered whether mu-
tants of p34/cdc2, which fail to respond correctly to either
cdc25 or wee1/mik1, might be resistant to Vpr expres-
sion. The HIV-1 Vpr expression plasmid was transformed
into three p34/cdc2 mutant strains, one which fails to
respond to cdc25 (cdc2-3w), and one which fails to re-
spond to wee1 (cdc2-1w), and the third in which the mik1
gene has been deleted (cdc2-1w, Dmik1). The results
showed that these three mutants, like strains with a nor-
mal cdc2 gene, were growth arrested by HIV-1 Vpr ex-
pression (Fig. 9). Similar results were observed by trans-
formation of these mutant yeast with HIV-2 Vpr or Vpx
FIG. 7. Effect of Vpr or Vpx expression on cell cycle progression
and SIV Vpr or Vpx (data not shown), indicating that Vprafter hydroxyurea synchronization. Cells were grown in the presence
or Vpx does not act directly through any of these cdc2or absence of thiamine and synchronized in S phase with hydroxyurea
as described under Materials and Methods. Cells cycle progression regulators.
following removal of hydroxyurea was monitored by flow cytometry. As
described, the timing of HU removal and shifting to thiamine-free me-
DISCUSSIONdium were coordinated so that the onset of expression of the Vpr or
Vpx proteins (which takes 9 hr) preceded removal of HU by 1 hr. Cells
In the present study we have found that expression ofwere incubated a further 10 hr following removal of HU. (A) HIV-1 Vpr
cells / thiamine after 4 hr in HU (early S phase arrest). (B) HIV-1 Vpr HIV-1 Vpr or HIV-2 and SIV Vpr or Vpx results in cell
cells/ thiamine, 10 hr after removal of HU (control for ability to recover cycle arrest in the yeast S. pombe. In addition, expression
from HU treatment and resume cell cycle progression). (C) HIV-1 Vpr of HIV-1 Vpr results in a rapid loss of viability. These
cells0 thiamine, 10 hr after removal of HU. (D) SIV Vpr cells0 thiamine,
10 hr after removal of HU. (E) SIV Vpx cells 0 thiamine, 10 hr after
removal of HU.
7B). In contrast, cells allowed to express HIV-1 Vpr or
SIV Vpr or Vpx had a significant fraction of the population
with DNA contents indicative of cells either in G1 or very
early S phase (Figs. 7C –7E), suggesting that the pres-
ence of Vpr or Vpx attenuates progression through S-
phase.
Suppression of p34/cdc2 kinase activity in yeast
expressing HIV-1 Vpr or SIV Vpr or Vpx
FIG. 8. Effect of Vpr and Vpx expression of p34/cdc2 kinase activity.
The primary regulators of G1/S and G2/M progression Cell extracts were prepared from exponentially growing cells. Samples
are indicated along the y-axis. Samples listed as ‘‘0 thiamine’’ werein eukaryotic cells are the cyclin-dependent kinases
intially grown in medium containing thiamine, harvested by centrifuga-(cdks) of which p34/cdc2 of S. pombe is the prototype
tion, washed in sterile water, then reinoculated in MM lacking thiamine(Broek et al., 1991; Nurse, 1994). In mammalian cells this
and incubated for 15 hr prior to preparing extracts. H1 kinase assays
enzyme is apparently inactivated by the expression of were performed as described under Materials and Methods. The level
HIV-1 Vpr (He et al., 1995; Re et al., 1995). Since p34/ of activity in SP130 cells alone was set as 100% and all samples are
scaled relative to this level.cdc2 is required for both the G1/S and G2/M transitions
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severe effect than HIV-1 Vpr in human 293 cells (Marzio
et al., 1995) and expression of SIVagm Vpx has a more
severe effect on CV-1 cells than on HeLa cells (Planelles
et al., 1996). Thus, it might initially be surprising that
expression of all these proteins should affect cell prolifer-
ation in a simpler eukaryote such as S. pombe. It should,
however, be noted that many of the proteins that regulate
cell proliferation in yeast can be functionally comple-
mented by human homologues (Moreno et al., 1991;
Nurse, 1994). Thus, the ability of Vpr and Vpx proteins to
affect cell proliferation might be mediated via the basic
cell cycle control machinery. Our observation that p34/
cdc2 kinase activity is significantly reduced in cells ex-
pressing SIV Vpr or Vpx, which do not have the same
viability loss as cells expressing HIV-1 Vpr, and which
still continue to grow (resulting in elongated cdc-like
cells), is consistent with this hypothesis. Furthermore,
the fact that these proteins have different effects de-
pending on cell type helps explain in part why we see
some differences in the phenotype caused by expression
of Vpr and Vpx in S. pombe. In addition, levels of expres-
sion may have a significant impact on apparent pheno-
type, especially given that HIV-1 Vpr appears to be cyto-
toxic when expressed in yeast. Expression levels may
also explain the differences between our results and a
previous study examining the consequences of HIV-1 Vpr
expression in S. pombe (Zhao et al., 1996), since this
previous study used a different version of the nmt1 pro-
moter than we have used in the present study. The use
of promoters with different transcription rates would be
a useful approach to clarifying this issue.FIG. 9. Genetic analysis of Vpr-dependent inhibition of cell prolifera-
tion. Strains of S. pombe with normal or a mutant cdc2 allele were The varying effects of the HIV and SIV proteins on the
transformed with the pREP41-HIV-1-Vpr expression plasmid to deter- S. pombe cell cycle is also consistent with the classifica-
mine if the cell cycle inhibitory effect was mediated through the known
tion of the primate lentiviruses, in which HIV-1 and HIV-p34/cdc2 regulators, cdc25, wee1, or mik1. (A) Cells grown with thia-
2/SIVmac have been divided into two distinct phylogeneticmine (repressing conditions). (B) Cells grown without thiamine (ex-
lineages (Franchini and Reitz, 1994). Our finding that thepressing conditions). (1) SP130 cells (normal cdc2 gene); (2) cdc2-1w
(defective response to wee1); (3) cdc2-3w (defective response to HIV and SIV proteins differ with regard to how cytotoxic
cdc25); (4) cdc2-1w, Dmik1 (defective response to wee1 and deletion they are in S. pombe may be a consequence of differ-
of mik1).
ences in their normal functions in vivo with regard to
their respective roles in the viral life cycle and cellular
pathogenesis, as compared to the HIV-1 Vpr protein.results are consistent with previous studies in which HIV-
1 Vpr was reported to cause cell cycle arrest in both These results are also consistent with the recent report
that SIVmac provirus lacking either Vpr or Vpx are stillmammalian cells and in yeast (He et al., 1995; Jowett et
al., 1995; Macreadie et al., 1995; Re et al., 1995; Rogel capable of producing AIDS in rhesus monkeys, while the
Vpr/Vpx double mutant is severely attenuated in pathoge-et al., 1995; Zhao et al., 1996). Here, we have extended
the studies to include HIV-2 and SIV Vpr and Vpx and nicity in vivo (Gibbs et al., 1995), and with a report of
independent functions of HIV-2 and SIV Vpr and Vpx withdemonstrate that all these lentiviral proteins inhibit yeast
cell proliferation. While HIV-2 and SIV Vpr and Vpx also respect to nuclear import and cell cycle arrest in mamma-
lian cells (Fletcher et al., 1996). It would be interestingcause cell cycle arrest, they are not as cytotoxic as HIV-
1 Vpr in S. pombe. to express both SIV Vpr and Vpx coincidentally, in order
to determine whether a more severe phenotype, analo-Previous studies suggested that the cell cycle arrest
effects of Vpr and Vpx could be species-specific. Expres- gous to HIV-1 Vpr, is produced. These studies are cur-
rently in progress.sion of HIV-1 Vpr in HeLa cells, which are of human
origin, has a more severe effect than does expression in Although Vpr and Vpx have been shown to block cell
cycle in mammalian cells, the cytological consequencesCV-1 cells, which are of simian origin (Planelles et al.,
1996). Accordingly, expression of SIVmac239 Vpr has a less of their expression are still uncertain. In contrast to a
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recent study suggesting that HIV-1 Vpr is primarily cyto- dramatically inactivated in human cells and in yeast ex-
pressing HIV-1 Vpr (He et al., 1995; Re et al., 1995; Zhaostatic in human Jurkat T cell line (Bartz et al., 1996), our
data demonstrates that HIV-1 Vpr is highly cytotoxic in et al., 1996). Future studies will have to address whether
or not these proteins can directly affect p34/cdc2 kinaseS. pombe, with complete loss of the ability to proliferate
with a few hours. Neither SIV Vpr nor Vpx were this activity.
The inducible yeast expression system has also beencytotoxic, producing at most an approximately 50% loss
of viability. Furthermore, we do not anticipate that this is proven to be informative as we have been able to deter-
mine that HIV-1 Vpr does not act simply via cdc25, wee1,due to residual Vpr since all samples contained maximal
levels of Vpr at the time they were plated onto repressing or mik1, direct regulators of p34/cdc2 in S. pombe. These
results may indicate that Vpr and Vpx do indeed actmedium. It is not clear what the basis of this difference
is, but possible explanations include differences in levels directly on p34/cdc2, that they act through a novel path-
way, or that multiple actions occur which cannot be re-of expression and reversibility of target protein interac-
tion. If mammalian cells arrested by Vpr do eventually solved via a simple epigenetic explanation. Other possi-
ble pathways include interaction with cycling regulatorslose viability, it might be reasonable to propose that Vpr
plays an important role in the depletion of HIV-1-infected such as protein phosphatases type 2A (PP2A), which
acts as an inhibitor of cell entry into mitosis (Kinoshitacells, which normally occurs in vivo. Regardless, our re-
sults demonstrate that expression of Vpr and Vpx in S. et al., 1990) and regulates cytokinesis (Wera et al., 1995).
Future studies should address these questions. Towardpombe will provide a useful model system in which to
better understand the role of these proteins. that end we have recently been able to produce ex-
tragenic suppressers that survive in the presence of HIV-In mammalian cells, HIV-1 Vpr and SIV Vpr have been
shown to arrest the cell cycle after DNA replication, likely 1 Vpr. The isolation of the genes responsible for this
resistance to Vpr expression may define in vivo targetsin G2 phase (Bartz et al., 1996; He et al., 1995; Jowett et
al., 1995; Re et al., 1995). In our study, we have shown of this protein, and improve our understanding of HIV
pathogenesis.that in S. pombe HIV-1 Vpr, HIV-2 Vpr or Vpx, and SIV
Vpr or Vpx arrested cell proliferation both at G1/S and
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